Tricuspid valve disease and cardiac implantable electronic devices
European Heart Journal · 01.02.2024 · 45 (5) · 346-365
DOI: 10.1093/eurheartj/ehad783 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Heart Journal, online erschienen am 14.12.2023. Verfasst von Martin Andreas und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Medical University of Vienna, Level 7C, Waehringer Guertel 18-20, Vienna 1090, Austria. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Defibrillators, Implantable, Tricuspid Valve Insufficiency, Rheumatic Heart Disease. Die Arbeit wurde bisher 158-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Medical University of Vienna, Level 7C, Waehringer Guertel 18-20, Vienna 1090, Austria.
- Cardiac Pacing Unit, Cardiology Departement, University Hospital of Geneva, Geneva, Switzerland.
- Bern University Hospital, University of Bern, Bern, Switzerland.
- Discipline of Cardiology, SAOLTA Healthcare Group, Galway University Hospital, Health Service Executive, and University of Galway, Galway H91 YR71, Ireland.
- Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.
- Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
ORCID-Profile: Martin Andreas, Haran Burri, Fabien Praz, Suneet Mittal, Aldo Rinaldi, Marco Russo, Christophe Leclercq
Zitieren
APA
Andreas, M., Burri, H., Praz, F., Soliman, O., Badano, L., Barreiro, M., Cavalcante, J. L., de Potter, T., Doenst, T., Friedrichs, K., Hausleiter, J., Karam, N., Kodali, S., Latib, A., Marijon, E., Mittal, S., Nickenig, G., Rinaldi, A., Rudzinski, P. N., …, & Leclercq, C. (2024). Tricuspid valve disease and cardiac implantable electronic devices. European Heart Journal, 45(5), 346-365. https://doi.org/10.1093/eurheartj/ehad783
Vancouver
Andreas M, Burri H, Praz F, Soliman O, Badano L, Barreiro M, et al. Tricuspid valve disease and cardiac implantable electronic devices. European Heart Journal. 2024;45(5):346-365. doi:10.1093/eurheartj/ehad783
BibTeX
@article{Andreas2024,
author = {Andreas, Martin and Burri, Haran and Praz, Fabien and Soliman, Osama and Badano, Luigi and Barreiro, Manuel and Cavalcante, João L and de Potter, Tom and Doenst, Torsten and Friedrichs, Kai and Hausleiter, Jörg and Karam, Nicole and Kodali, Susheel and Latib, Azeem and Marijon, Eloi and Mittal, Suneet and Nickenig, Georg and Rinaldi, Aldo and Rudzinski, Piotr Nikodem and Russo, Marco and Starck, Christoph and von Bardeleben, Ralph Stephan and Wunderlich, Nina and Zamorano, José Luis and Hahn, Rebecca T and Maisano, Francesco and Leclercq, Christophe},
title = {Tricuspid valve disease and cardiac implantable electronic devices},
journal = {European Heart Journal},
year = {2024},
volume = {45},
number = {5},
pages = {346--365},
doi = {10.1093/eurheartj/ehad783}
}
EUVIMED